Future milestones in cancer prevention, treatment and cure will be defined by the action we take today.
The Big picture…
The Big Picture
.CANCERRESEARCH is a collaborative initiative facilitated by the Australian Cancer Research Foundation. Its focus is to bring together news, information, and leading opinion on cancer treatment, prevention, diagnosis and cure. We want you to be a part of the .CANCERRESEARCH community...
Please click here to learn more.
Types of Cancer
You Are Here
Donate Here
Milestones
Ten years ago, the first HPV immunisation was administered in Australia. Over 150 million doses of vaccine have been delivered worldwide since.
Human papillomaviruses (HPV) are the major cause of cervical cancer, recognised worldwide as one of the biggest killers among all cancers in women. In 2006, the release of world’s first vaccine protecting against infection with HPV was hailed as a major medical milestone. The HPV vaccine was developed by a team of University of Queensland […]
In 2003, one of the most ambitious international scientific research projects ever attempted, the Human Genome Project, was declared complete.
The BRCA1 gene – the first gene associated with hereditary breast cancer – was identified and cloned (isolated) in 1994. A year later a second breast cancer gene, BRCA2, was cloned.
First discovered in the 1980s, the MYC gene is known to be important in many types of cancer, including breast cancer, lung cancer and several blood cancers.
The discovery of telomerase initially helped biologists understand how DNA at chromosome ends were replicated, but the significance was far greater than expected.
in 1979, arguably one of the cell’s most important tumour suppressor genes was discovered: the gene p53.
Tamoxifen is a drug credited with saving the lives of hundreds of thousands of women around the world, and extending the lives of millions more.
The first bone marrow transplant paved the way for a life-saving therapy that is now standard for patients with blood cell disorders, including leukaemia.
